RxDoctor Payments Data

Jean-Pierre Obeid, MD

Radiation Oncology · Vero Beach, FLNPI 1770012411

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $28,257 of the $29,768 with a category attached, or 94.9%. MIM Software Inc. accounts for 94.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $14,858 and has fallen 98.7% since, to $188 in 2025. Among radiation oncology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$29,768in general payments, 2019–2025

Across 14 payments — averaging $2126.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • MIM Software Inc.$28K
  • Carl Zeiss Meditec USA, Inc.$1K
  • Boston Scientific$149
  • Heron Therapeutics, Inc.$125
  • Johnson & Johnson$66
  • Caris MPI, Inc.$65
  • plus $80 from 2 others

What the payments were for

  • Consulting fees$28,25795%
  • Travel & lodging$5262%
  • Food & beverage$4852%
  • Education$5002%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,768 in reported general payments places this provider in the 90th percentile of 465 radiation oncology providers in Florida.

See all radiation oncology providers in Florida

Medicare billing

Part B allowed, 2024
$146,353
Medicare patients
265
Services billed
1,640

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl17$130

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Vero Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →